Keyphrases
Essential Thrombocythemia
100%
Optimal Therapy
100%
Interferon Therapy
100%
Polycythemia Vera
100%
Phase II Trial
100%
Interferon-α (IFN-α)
66%
Recombinant Interferon
66%
Patient Preference
33%
World Wide Web
33%
Diagnostic Criteria
22%
Single-arm Study
22%
Life-limiting Conditions
11%
Biological Effects
11%
Biological Activity
11%
Stem Cells
11%
Megakaryocytes
11%
Hemoglobin Value
11%
World Health Organization Criteria
11%
Clinical Practice
11%
Medicine and Dentistry
Interferon
100%
Essential Thrombocythaemia
100%
Polycythemia vera
100%
Arm
33%
Biological Activity
22%
Diseases
22%
Diagnosis
22%
Clinical Study
11%
Megakaryocyte
11%
Stem Cell
11%
Pharmacology, Toxicology and Pharmaceutical Science
Polycythemia vera
100%
Interferon
100%
Thrombocythemia
100%
Diseases
22%
Clinical Study
11%
Biological Activity
11%
Biochemistry, Genetics and Molecular Biology
Essential Thrombocythaemia
100%
Interferon
100%
Biological Activity
28%
Clinical Study
14%
Stem Cell
14%
Megakaryocyte
14%
Nursing and Health Professions
Recombinant Alpha Interferon
66%
Patient Decision Making
22%